CYM50179 is a potent and selective agonist of the S1P4 receptor (sphingosine-1-phosphate receptor 4), with an EC50 of 46 nM; it has potential applications in the treatment of autoimmune diseases, viral infections, and thrombocytopenia via modulation of lysophospholipid receptor signaling.